Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma
Alec Kacew(Hospital of the University of Pennsylvania), Glenn J. Hanna(Dana-Farber Cancer Institute), Chrysalyne D. Schmults(Dana-Farber Brigham Cancer Center), Guilherme Rabinowits(Baptist Hospital of Miami), Ethan Harris(University of Chicago), Nicole R. LeBoeuf(Dana-Farber Brigham Cancer Center), Robert I. Haddad(Georgetown University), Laura E. MacConaill(Brigham and Women's Hospital), Jochen H. Lorch(Northwestern University), Nicole G. Chau(University of British Columbia), Manisha Thakuria(Brigham and Women's Hospital)
Cited by 33
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k